default author photo

Barbara Martin

Bavarian Nordic GmbH

Germany

SCHOLARLY PAPERS

1

DOWNLOADS

0

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Safety and Immunogenicity of Abncov2, a Virus-Like Particle Based Vaccine Against Covid-19 in a Phase 2 Trial in Healthy Adults

16TH VACCINE CONGRESS:P1.30
Posted: 19 Oct 2022
Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic, Inc., Bavarian Nordic GmbH, Bavarian Nordic GmbH and Bavarian Nordic GmbH

Abstract:

Loading...